Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]. (6th November 2014) - Bhardwaj, Nina; Merad, Miriam; Kim-Schulze, Seunghee; Crowley, Beth; Davis, Thomas; Keler, Tibor; Salazar, Andres; Brody, Joshua